Asklepios Group: Positive business performance in first quarter - Confident
outlook for 2024

EQS-News: Asklepios Kliniken / Key word(s): Quarterly / Interim
Statement/Quarter Results
Asklepios Group: Positive business performance in first quarter - Confident
outlook for 2024

23.05.2024 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Asklepios Group: Positive business performance in first quarter - Confident
outlook for 2024

* Consolidated revenue up year-on-year at EUR 1,414.5 million

* Consolidated net income (EAT) of EUR 18.5 million

* Increase in patient and employee numbers

Hamburg, 23 May 2024. Asklepios Kliniken GmbH & Co. KGaA has enjoyed a solid
economic performance in the first three months of the 2024 financial year.
The Asklepios Group can report a positive development despite the ongoing
uncertainty in the healthcare sector and global economic challenges.

Asklepios has further consolidated its role as a reliable healthcare
partner: 919,532 patients in total were treated in the Asklepios Group's
healthcare facilities in the first three months of the 2024 financial year
(3M 2023: 860,826). The number of inpatients was 196,297, 1.9% higher than
in the previous year (3M 2023: 192,731), while the number of outpatients
rose by 8.3% to 723,235 (3M 2023: 668,095).

Asklepios employed 50,272 full-time equivalents on average in the period
from January to March (3M 2023: 49,393). This increase is as a result of
strategic recruitment activities and the successful hiring of skilled
workers from Germany and abroad.

Revenue increased by 5.4% year-on-year to EUR 1,414.5 million in the first
quarter of 2024 (3M 2023: EUR 1,341.8 million). Staff costs rose by EUR 49.6
million as against the same period of the previous year to EUR 974.5 million
as a result of pay increases and the growth in headcount. The staff costs
ratio matched the previous year's level at 68.9% (3M 2023: 68.9%).
Consolidated net income (EAT) grew to EUR 18.5 million (3M 2023: EUR 9.2
million).

Marco Walker, CEO of Asklepios Kliniken, commented: "The satisfactory
development in the first quarter of 2024 is a clear sign that we are well
positioned despite the challenging situation in the German healthcare
sector. Our long-term business strategy and the tireless efforts of our
employees give us cause to be confident in our outlook for the remainder of
the financial year."

Joachim Gemmel, CEO of Asklepios Kliniken, said: "Our economic stability
allows us to look forward with confidence to the far-reaching changes in the
healthcare sector. At the same time, we are calling on politicians to create
reliable and stable solutions for good healthcare with the upcoming hospital
reform."

Investments including subsidies amounted to EUR 67.4 million. (3M2023: EUR
77.4 million).

Hafid Rifi, CFO of Asklepios Kliniken, said: "We are operating on a solid
basis and are now setting the right course to further consolidate and expand
our market position. Moving forward, we will continue to rely on a stable
capital structure and long-term financing strategies."

On the basis of its size and structure, the Asklepios Group is robustly
positioned and can respond flexibly to changes, even in a volatile market
environment. The upcoming hospital reform will define the 2024 financial
year and shape the Group's performance. In this context, Asklepios is
continuing to campaign for the government to take swift and effective action
to relieve the pressure on hospitals. The Group's stated aim for the
financial year is still to continuously increase its operating result and
thus achieve greater economic flexibility for the expansion of first-class
healthcare in Germany.

About Asklepios

Asklepios Kliniken is one of the leading private operators of hospitals and
healthcare facilities in Germany. The hospital group stands for highly
qualified care for its patients, with a clear commitment to medical quality,
innovation and social responsibility. On this basis, Asklepios has developed
dynamically since it was founded more than 35 years ago. The Group now has
more than 164 healthcare facilities across Germany, including acute care
hospitals for all levels of care, university hospitals, specialist clinics,
psychiatric and forensic facilities, rehabilitation clinics, nursing homes
and medical centres. More than 3.5 million patients were treated at the
Asklepios Group's facilities in the 2023 financial year. The company has
more than 68,000 employees.

IR contact
Mirjam Constantin
Head of Corporate & ESG Reporting / Investor Relations
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3 - 61462 Königstein-Falkenstein
Phone: +49 61 74 90-1166
ir@asklepios.com

PR contact
Rune Hoffmann
Head of Corporate Communication & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226 - 22307 Hamburg
Phone: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639
presse@asklepios.com

Visit Asklepios online, on Facebook or on YouTube
www.asklepios.com
gesundleben.asklepios.com
www.facebook.com/asklepioskliniken
www.youtube.com/asklepioskliniken

Subscribe to the Asklepios newsletter
https://www.asklepios.com/konzern/newsletter-anmeldung/
Nursing blog: " Wir sind Pflege"


---------------------------------------------------------------------------

23.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

1908785 23.05.2024 CET/CEST